We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current EVOK market cap is 6.57M. The company's latest EPS is USD -5.2436 and P/E is -0.84.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.56M | 1.68M | 1.74M | 2.55M | 2.65M |
| Operating Income | -1.6M | -1.89M | -1.5M | -1.22M | -1.29M |
| Net Income | -1.69M | -1.99M | -1.58M | -1.27M | -1.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 23k | 1.62M | 2.51M | 5.18M |
| Operating Income | -7.16M | -13.05M | -8.15M | -7.79M | -7.43M |
| Net Income | -7.13M | -13.16M | -8.54M | -8.22M | -7.79M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.85M | 7.07M | 12.45M | 12.14M | 14.15M |
| Total Liabilities | 8.73M | 9.65M | 8.96M | 9.47M | 9.77M |
| Total Equity | -874k | -2.58M | 3.5M | 2.67M | 4.39M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.4M | 9.43M | 10.57M | 11.85M | 7.07M |
| Total Liabilities | 2.02M | 12.65M | 7.02M | 7.77M | 9.65M |
| Total Equity | 4.38M | -3.22M | 3.56M | 4.09M | -2.58M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.88M | -4.99M | -2.58M | -3.4M | -4.22M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | -119k | 7.54M | 7.84M | 10.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.76M | -6.63M | -12.35M | -6.6M | -4.99M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 6.11M | 9.04M | 13.43M | 7.3M | -119k |
| Market Cap | 6.57M |
| Price to Earnings Ratio | -0.84 |
| Price to Sales Ratio | 1.27 |
| Price to Cash Ratio | 1.39 |
| Price to Book Ratio | -2.55 |
| Dividend Yield | - |
| Shares Outstanding | 1.49M |
| Average Volume (1 week) | 18.18k |
| Average Volume (1 Month) | 37.51k |
| 52 Week Change | -64.24% |
| 52 Week High | 13.80 |
| 52 Week Low | 3.54 |
| Spread (Intraday) | 0.75 (15.62%) |
| Company Name | Evoke Pharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.evokepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
